{"id":6748,"date":"2026-02-14T22:58:15","date_gmt":"2026-02-14T22:58:15","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/6748\/"},"modified":"2026-02-14T22:58:15","modified_gmt":"2026-02-14T22:58:15","slug":"roche-pharma-commits-1-5-billion-swiss-franc-investment-in-india-over-next-five-years","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/6748\/","title":{"rendered":"Roche Pharma commits 1.5 billion Swiss franc investment in India over next five years"},"content":{"rendered":"<p>Swiss healthcare major <a ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#Industry#href\" href=\"https:\/\/m.economictimes.com\/topic\/roche-pharma\" target=\"_blank\" rel=\"nofollow noopener\">Roche Pharma<\/a> is committing to invest 1.5 billion <a ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#Industry#href\" href=\"https:\/\/m.economictimes.com\/topic\/swiss-franc\" target=\"_blank\" rel=\"nofollow noopener\">Swiss Franc<\/a> in India over the next five years, a senior company executive said on Wednesday.<\/p>\n<p>Speaking at the India-European Free Trade Association (EFTA) Prosperity Summit here, <a ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#Industry#href\" href=\"https:\/\/m.economictimes.com\/topic\/roche\" target=\"_blank\" rel=\"nofollow noopener\">Roche<\/a> Pharma Area Head CEETRIS (Central Eastern Europe, Turkiye, Russia and Indian Subcontinent) Francois du <a ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#Industry#href\" href=\"https:\/\/m.economictimes.com\/topic\/toit\" target=\"_blank\" rel=\"nofollow noopener\">Toit<\/a> said the company&#8217;s investment underlines a long-term commitment to the Indian market.<br \/>&#8220;We currently have over 5,000 employees in India. We commit to investing 1.5 billion Swiss Francs at a minimum into our core businesses over the next five years,&#8221; du Toit said.<\/p>\n<p>The company sees India not only as an important market, but also as a hub for innovation, he added.<\/p>\n<p>The company&#8217;s investment will go into three critical areas, including R&amp;D, he said.<\/p>\n<p><img decoding=\"async\" alt=\"ET logo\" src=\"https:\/\/www.europesays.com\/ch\/wp-content\/uploads\/2026\/02\/118783427.cms.png\" width=\"90%\"\/>Live Events<br \/>Roche would also be working with <a ref=\"dofollow\" data-ga-onclick=\"Inarticle articleshow link click#Industry#href\" target=\"_blank\" href=\"https:\/\/economictimes.indiatimes.com\/wealth\/insure\/ayushman-bharat-yojana\" rel=\"nofollow noopener\">Ayushman Bharat<\/a> and several other schemes to bring its innovative products to as many patients in India as possible, he added.<br \/>India&#8217;s free trade agreement (FTA) with the four-nation bloc, the European Free Trade Association (EFTA), comes into effect from Wednesday.<\/p>\n","protected":false},"excerpt":{"rendered":"Swiss healthcare major Roche Pharma is committing to invest 1.5 billion Swiss Franc in India over the next&hellip;\n","protected":false},"author":2,"featured_media":6749,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[124],"tags":[4127,5496,5495,251,134,5497,470,5498],"class_list":{"0":"post-6748","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-roche","8":"tag-ayushman-bharat","9":"tag-india-european-free-trade-association-efta","10":"tag-investment-in-india","11":"tag-rd","12":"tag-roche","13":"tag-roche-pharma","14":"tag-swiss-franc","15":"tag-toit"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/6748","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=6748"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/6748\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/6749"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=6748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=6748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=6748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}